Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing By Launching Two Global Trials
Eli Lilly and Company (NYSE: LLY) announced it will begin enrolling patients this month in two separate but identical Phase III clinical trials of solanezumab(i), previously referred to as LY2062430, an anti-amyloid beta monoclonal antibody being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer"s disease. The trials, called EXPEDITION and EXPEDITION 2, will each include a treatment period that lasts 18 months and are expected to enroll a total of 2,000 patients age 55 and over from 16 countries.
generic viagra online
Low Birth Weight Linked To Psychosis-like Symptoms
Low birth weight babies are at greater risk of developing psychosis-like symptoms as they grow up, research suggests.
News of the day
Two Drug-Related Legislative Plans Pose Problems For Stakeholders
"The Senate dealt a blow to the drug lobby Thursday by voting to permit people in the United States to order lower-cost drugs from Canada over the Internet," the Associated Press/Arizona Republic reports. The drugs in question are often made in the U.S., and then sold abroad for lower prices than at home because because of government policies in many other countries. The bill would make it legal to re-import those drugs more readily. The drug provision passed as an amendment to a Department of Homeland Security funding bill and was introduced by Republican Louisianna Sen. David Vitter (Taylor, 7/9).
Diagnostics

Donors To Reevaluate Support For Myanmar's Fight Against HIV/AIDS

The AP/KTVZ.com examines how after years of strained relationships between the "military-run nation" of Myanmar and international donors that led to a large reduction in HIV/AIDS funding, donors are considering reinvesting in the country"s HIV/AIDS programs. According to AP/KTVZ.com, "Myanmar receives only about $3 per capita in aid, compared with $23 for Vietnam and $50 for Laos." An estimated 240,000 people in Myanmar are living with HIV. Of those, "about 76,000 are in need of the life-saving antiretroviral treatment, but less than a quarter of them - about 18,000 - are getting it ò€¦ Donors have long feared that aid would only bolster the iron-hand rule of the military government," the news service writes. While aid groups say that the Myanmar government is fully away of the HIV/AIDS problem, "the regime"s priorities lie elsewhere," according to the AP/KTVZ.com. The article examines how the Global Fund to Fight AIDS, Tuberculosis and Malaria, which began closing its grants in Myanmar in 2005, "is now considering an application by Myanmar for $320 million in funding, with the goal of treating 42,000 new AIDS cases within five years." The AP also addresses how the U.S. and E.U. are reevaluating their assistance policies toward Myanmar and features several clinics who care for HIV/AIDS patients (7/26). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009